Abstract
STUDY QUESTION Is SARS-CoV-2 receptor, angiotensin-converting enzyme 2 (ACE 2) expressed in the human endometrium during the menstrual cycle, and does it participate in endometrial decidualization?
SUMMARY ANSWER ACE2 protein is highly expressed in human endometrial stromal cells during the secretory phase and is essential for human endometrial stromal cell decidualization.
WHAT IS KNOWN ALREADY ACE2 is expressed in numerous human tissues including the lungs, heart, intestine, kidneys and placenta. ACE2 is also the receptor by which SARS-CoV-2 enters human cells.
STUDY DESIGN, SIZE, DURATION Proliferative (n = 9) and secretory (n = 6) phase endometrium biopsies from healthy reproductive-age women and primary human endometrial stromal cells from proliferative phase endometrium were used in the study.
PARTICIPANTS/MATERIALS, SETTING, METHODS ACE2 expression and localization were examined by qRT-PCR, Western blot, and immunofluorescence in both human endometrial samples and mouse uterine tissue. The effect of ACE2 knockdown on morphological and molecular changes of human endometrial stromal cell decidualization were assessed. Ovariectomized mice were treated with estrogen or progesterone to determine the effects of these hormones on ACE2 expression.
MAIN RESULTS AND THE ROLE OF CHANCE In human tissue, ACE2 protein is expressed in both endometrial epithelial and stromal cells in the proliferative phase of the menstrual cycle, and expression increases in stromal cells in the secretory phase. The ACE2 mRNA (P < 0.0001) and protein abundance increased during primary human endometrial stromal cell (HESC) decidualization. HESCs transfected with ACE2-targeting siRNA were less able to decidualize than controls, as evidenced by a lack of morphology change and lower expression of the decidualization markers PRL and IGFBP1 (P < 0.05). In mice during pregnancy, ACE2 protein was expressed in uterine epithelial and stromal cells increased through day six of pregnancy. Finally, progesterone induced expression of Ace2 mRNA in mouse uteri more than vehicle or estrogen (P < 0.05).
LARGE SCALE DATA N/A.
LIMITATIONS, REASONS FOR CAUTION Experiments assessing the function of ACE2 in human endometrial stromal cell decidualization were in vitro. Whether SARS-CoV-2 can enter human endometrial stromal cells and affect decidualization have not been assessed.
WIDER IMPLICATIONS OF THE FINDINGS Expression of ACE2 in the endometrium allow SARS-CoV-2 to enter endometrial epithelial and stromal cells, which could impair in vivo decidualization, embryo implantation, and placentation. If so, women with COVID-19 may be at increased risk of early pregnancy loss.
STUDY FUNDINGS/COMPETING INTEREST(S) This study was supported by National Institutes of Health / National Institute of Child Health and Human Development grants R01HD065435 and R00HD080742 to RK and Washington University School of Medicine start-up funds to RK. The authors declare that they have no conflicts of interest.
Introduction
Although much of the focus during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)/coronavirus disease 2019 (COVID-19) pandemic has been on respiratory symptoms, some reports suggest that SARS-CoV-2 and the related Middle East Respiratory Syndrome Coronavirus can cause pregnancy complications such as pre-term birth and miscarriages (Favre et al. 2020). Additionally, a few reports noted that pregnant women with COVID-19 had maternal vascular malperfusion and decidual arteriopathy in their placentas (Schwartz and Dhaliwal 2020; Shanes et al. 2020a), and a recent clinical case study reported a second-trimester miscarriage in a woman with COVID-19 (Baud et al. 2020). However, whether SARS-CoV-2 infects the uterus has not been determined.
It seems likely that SARS-CoV-2 could infect the uterus because its receptor, Angiotensin Converting Enzyme 2 (ACE2), is expressed fairly ubiquitously in human tissues such as the lungs, heart, intestine, kidneys, and placenta (Hamming et al. 2004; Harmer et al. 2002; Riviere et al. 2005). Moreover, ACE2 functions by cleaving the vasoconstrictor angiotensin II to the vasodilator angiotensin (1-7). As a component of the renin–angiotensin system, ACE2 plays an important role in regulating maternal blood pressure during pregnancy. ACE2 is expressed in the rat uterus during mid- and late pregnancy (Merrill et al. 2002; Neves et al. 2008). In addition, ACE2 mRNA expression was noted in the uterus of both rats (Brosnihan et al. 2012) and humans (Vaz-Silva et al. 2009), in which its expression may be higher in the secretory phase than in the proliferative phase of the menstrual cycle (Vaz-Silva et al. 2009).
During the secretory phase, the uterine stromal cells prepare for embryo implantation by undergoing a progesterone-mediated differentiation process called decidualization. In this process, the stromal cells divide, change from a fibroblastic to an epithelioid morphology, and change their pattern of gene expression. Decidualization is essential for trophoblast invasion and placentation (Carson et al. 2000; Norwitz et al. 2001; Wilcox et al. 1999), and defects in this process may underlie early pregnancy loss in some women. Given the important function of the uterine stroma and the possibility that SARS-CoV-2 could infect the uterus, our goal here was to determine whether ACE2 is expressed in endometrial stromal cells, is regulated by progesterone, and is required for decidualization.
Results and Discussion
We first sought to determine whether ACE2 is expressed in the endometrium and whether its expression differs according to the phase of the menstrual cycle. Thus, we obtained endometrial biopsies from women during the proliferative or secretory phase of the menstrual cycles and performed immunofluorescence with an ACE2-specific antibody. In the proliferative phase, ACE2 was highly expressed in epithelial cells than in stromal cells (Fig. 1A). However, in the secretory phase, ACE2 expression was increased in the stromal cells (Fig. 1A). Thus, we wondered whether ACE2 expression increased during in vitro decidualization of human endometrial stromal cells (HESCs). We isolated primary HESCs, exposed them to decidualizing conditions, and confirmed that expression of the decidualization markers Prolactin (PRL) and Insulin-like growth factor-binding protein-1 (IGFBP1) increased over six days. ACE2 mRNA also increased over this time (Fig. 2A). Consistent with this finding, ACE2 protein abundance increased during decidualization, as shown by both immunoblotting (Fig. 2B) and immunofluorescence (Fig. 2C). As expected, ACE2 protein predominantly localized in the cytoplasm and cell membrane of decidualized HESCs.
(A) Representative images showing immunolocalization of ACE2 (green) in proliferative (n=9) and secretory (n=6) phase endometrium. Blue stain is DAPI. G, gland; S, stroma. Red arrows indicate ACE2-positive cells, and the dashed white line marks the epithelium. (B) Rabbit IgG was used as an isotype control for staining. Scale bar: 100 μm.
(A) Abundances of ACE2, PRL, and IGFBP1 transcripts from human endometrial stromal cells (HESCs) induced to decidualize for the indicated numbers of days. Representative data from three replicates (n=3) from one subject sample are shown as mean ± SEM. The experiment were repeated three times. *P < 0.05, **P < 0.01, and ****P < 0.0001. (B) Western blot of ACE2 from HESCs cultured in decidualization media for the indicated numbers of days; GAPDH was used as an internal loading control. (C) Immunofluorescence detection of ACE2 (green) in HESCs cultured with vehicle or decidualization media (EPC) for the indicated numbers of days. Blue stain is DAPI. Red arrowhead indicates a decidualized cell, and blue arrowheads indicate non-decidualized cells. Scale bar: 100 μm.
Next, we wondered whether ACE2 was required for primary HESC decidualization. To answer this question, we transfected HESCs with control or ACE2-targeting siRNAs and then exposed the cells to decidualization conditions. HESCs transfected with control siRNA changed from fibroblastic to epithelioid morphology (Fig. 3A) and had increased expression of the decidualization markers PRL and IGFBP1 (Fig. 3B). In contrast, HESCs transfected with ACE2-targeting siRNA did not show a morphology change over six days (Fig. 3A) and expressed significantly less PRL, IGFBP1, and ACE2 than control cells (Fig. 3B-C). These results demonstrate that ACE2 is essential for endometrial stromal cell decidualization.
(A) Morphology of human endometrial stromal cells (HESCs) transfected with control or ACE2 siRNA at day 0 or after six days of culture in decidualization conditions. Red arrows indicate non-decidualized cells, and the black arrow indicates a decidualized cell. Scale bar: 200 μm. (B) Abundances of ACE2, PRL, and IGFBP1 transcripts in HESCs transfected with control or ACE2 siRNAs and induced to decidualize for the indicated numbers of days. (C) Western blot of ACE2 protein from HESCs transfected with control or ACE2 siRNA; GAPDH was used as an internal loading control. Representative data from three replicates from one subject sample are shown as mean ± SEM. The experiment was repeated three times; *P < 0.05, **P < 0.01, and ***P < 0.001.
Finally, we examined the expression of ACE2 in the endometrium during early pregnancy in mice. We mated female wild-type mice with males of proven fertility and then stained their uteri with an ACE2-specific antibody at different days in early pregnancy. In days one through four, ACE2 localized to the cytoplasm and cell surface of epithelial and stromal cells. However, beginning on day three, strong ACE2 staining was seen in the cytoplasm of stromal cells. This staining was evident at least through day six, which is when robust decidualization occurs (Fig. 4). Given this change in ACE2 abundance during pregnancy, we wondered whether ACE2 expression was regulated by steroid hormones. To test this, we ovariectomized six-week-old mice, waited two weeks, treated the mice with either estrogen or progesterone for six hours, and then collected the uteri (Fig. 5A). Uteri from progesterone-treated mice expressed significantly more Ace2 mRNA than uteri from vehicle-treated mice, which expressed significantly more Ace2 mRNA than uteri from estrogen-treated (Fig. 5B). Consistent with this, immunofluorescence revealed that uteri from progesterone-treated mice had significantly more ACE2 protein in stromal cells than did uteri from vehicle- or estrogen-treated mice (Fig. 5C).
Shown are representative images of immunocytochemical localization of ACE2 in mouse uteri on the indicated days of pregnancy. LE, luminal epithelium; S, stroma; G, glands. Scale bar: 100 μm. White arrows indicate ACE2-positive cells. Samples from at least five mice were examined. All uteri were collected between 9:00 am and 10:00 am on the indicated days of pregnancy.
(A) Experimental protocol and hormone treatment. E2, estrogen; P4, progesterone. Relative Ace2 mRNA abundance after six hours of estrogen or progesterone treatment. Data are presented as mean ± SEM (n=5 mice per group). *P< 0.05, **P< 0.01. (C) Representative cross-sectional images of uteri stained for ACE2 (green) and DNA (blue); LE, luminal epithelium; S, stroma; G, glands, scale bar: 100 μm.
Together, our findings suggest that ACE2 expression in the endometrial stroma is promoted by progesterone in both humans and mice. Moreover, we show that ACE2 is required for human stromal cell decidualization. Given the high ACE2 expression in the human endometrium, SARS-CoV-2 may be able to enter endometrial stromal cells and elicit pathological manifestations in women with COVID-19. If so, women with COVID-19 may be at increased risk of early pregnancy loss. As more data become available, epidemiologists and obstetricians should focus on this important issue and determine whether women who intend to get pregnant should undergo additional health screenings during the COVID-19 pandemic.
Materials and Methods
Human ethical approval and endometrial stromal cell isolation
Informed consent was obtained in accordance with a protocol approved by the Washington University in St. Louis Institutional Review Board (IRB ID #: 201612127). Additionally, all work involving human subjects followed the guidelines of the World Medical Association Declaration of Helsinki. Human endometrial biopsies of healthy, reproductive-age women were collected during the proliferative phase (days 9 to 12) and secretory phase (days 14 to 26) of the menstrual cycle. HESCs were isolated as described previously (Camden et al. 2017; Michalski et al. 2018). Briefly, proliferative phase endometrial biopsies were minced with sterile scissors and then digested in DMEM/F12 medium containing 2.5 mg/ml collagenase (Sigma-Aldrich, Saint Louis, MO, USA) and 0.5 mg/ml DNase I (Sigma-Aldrich) for 1.5 hours at 37 °C. Then, detached cells were centrifuged at 800g for 2.5 min. collected, and layered over a Ficoll-Paque reagent layer and centrifuged for 30 min. at 400g (GE Healthcare Biosciences, Pittsburgh, PA) to remove lymphocytes. The HESC fraction from the top layer was collected and filtered through a 40 μm nylon cell strainer (BD Biosciences, Franklin Lakes, NJ). HESCs collected from the filtrate were suspended in DMEM/F-12 media containing 10% FBS, 100 U/ml penicillin, and 0.1 mg/ml streptomycin at 37 °C with 5% CO2. Independent HESC lines isolated from three patients were used for each experiment. Represented data are from a single patient with three technical replicates.
Transfection and HESC decidualization
HESCs were grown in a six-well culture plate to 60%–70% confluence and transfected with 60 pmol of non-targeting siRNA (D-001810-10-05) or siRNAs targeting ACE2 (L-005755-00-0005) (GE Healthcare Dharmacon Inc., Lafayette, CO) in Lipofectamine 2000 reagent (Invitrogen Corporation, Carlsbad, USA) as described previously (Camden et al. 2017). After 48 hours, HESCs were decidualized by culturing in EPC (Estrogen, Medroxy Progesterone Acetate and cAMP) medium (1x Opti-MEM reduced-serum media containing 2% FBS, 100 nM estradiol [cat. no. E1024, Sigma-Aldrich], 10 μM Medroxyprogesterone17-acetate [cat. no. M1629, Sigma-Aldrich], and 50 μM 8-Bromoadenosine 3′,5′-cyclic monophosphate sodium salt [cat. no. B7880, Sigma-Aldrich]). The EPC medium was changed every 48 hours until day six, when the cells were harvested for RNA isolation with the total RNA isolation kit (Invitrogen/Life Technologies, Grand Island, NY) or for protein isolation.
Quantitative real-time PCR
Total RNA was extracted from uterine tissues or HESCs by using the total RNA isolation kit (Invitrogen/Life Technologies) according to the manufacturer's instructions. RNA was quantified with a Nano-Drop 2000 (Thermo Scientific, Waltham, MA, USA). Then, 1 μg of RNA was reverse transcribed with the High-Capacity cDNA Reverse Transcription Kit (Thermo Scientific, Waltham, MA, USA). The amplified cDNA was diluted to 10 ng/μl, and quantitative PCR was performed with primers specified in Table S1 and Fast Taqman 2X mastermix (Applied Biosystems/Life Technologies, Grand Island, NY) on a 7500 Fast Real-time PCR system (Applied Biosystems/Life Technologies). Ribosomal RNA (18S) was used as an internal control for gene specific primers. (Camden et al. 2017; Kommagani et al. 2013; Kommagani et al. 2016).
SDS-PAGE and Western blotting
Protein extracts were prepared from HESCs as described previously (Oestreich et al. 2020). Briefly, total proteins were extracted by homogenizing cells in RIPA lysis buffer (cat. no. 9806, Cell Signaling Technology) and centrifuging at 14,000 g for 15 minutes at 4 °C. The supernatants were collected and protein was quantified with the BCA Protein Assay kit according to the manufacturer’s instructions (Pierce BCA protein assay kit, cat no. 23227). Lysates containing 40 μg of protein were loaded on a 4-15% SDS-PAGE gel, separated with 1x Tris-Glycine Running Buffer, and transferred to PVDF membranes on a wet electro-blotting system (all from Bio-Rad, USA), all according to the manufacturer’s directions. The PVDF membranes were washed, blocked for 1 hour in 5% non-fat milk in TBS-T (Bio-Rad, USA), and incubated with primary antibodies anti-ACE2 (1:1000, ab15348, Abcam) and anti-GAPDH (1:3000, #2118S Cell Signaling Technology, USA) in 5% BSA in TBS-T overnight at 4°C. Then, blots were probed with anti-Rabbit IgG conjugated with horseradish peroxidase (1:5000, #7074, Cell Signaling Technology) in 5% BSA in TBS-T for 1 hour at room temperature. Signal was detected by using the Immobilon Western Chemiluminescent HRP Substrate (Millipore, MA, USA), and blot images were collected with a Bio-Rad ChemiDoc imaging system (Kommagani et al. 2016).
Immunofluorescence
Formalin-fixed, paraffin-embedded sections (5 μm) of human endometrium and mouse uterus were deparaffinized in xylene, rehydrated in an ethanol gradient, and then boiled in antigen retrieval citrate buffer (Vector Laboratories Inc., CA, USA). Subsequently, sections were blocked with 2.5% goat serum in PBS (Vector laboratories) for one hour at room temperature, and then incubated overnight at 4°C with anti-ACE2 antibody (1:200, ab15348, Abcam) or normal rabbit IgG (#2729, Cell Signaling Technology). Then, sections were washed with PBS, incubated with Alexa Fluor 488-conjugated secondary antibody (Life Technologies) for one hour at room temperature, washed three times with PBS, and mounted with ProLong Gold Antifade Mountant with DAPI (cat. no. P36962 Thermo Scientific). Immunofluorescence images were captured on a confocal microscope (Leica DMI 4000B).
Immunocytochemistry
HESCs were grown on poly-L-Lysine coated coverslips in 12-well plates and allowed to decidualize for six days in EPC media as described above. Then, cells were fixed with 4% paraformaldehyde (Alfa Aesar, USA) in PBS) for 20 min. at room temperature, washed with PBS, and permeabilized with 0.2% Triton X-100 (Sigma Aldrich, USA) in PBS for 20 min. at room temperature. Then, cells were washed, blocked with 2.5% normal goat-serum (Vector laboratories) in PBS for 1 h at room temperature, and incubated overnight at 4°C with anti-ACE2 antibody (ab15348, Abcam, 1:200) in 2.5% normal goat serum. Cells were washed and incubated with Alexa Fluor 488-conjugated secondary antibodies (Life Technologies) for one hour at room temperature and mounted with ProLong Gold Antifade Mountant with DAPI (Thermo Scientific). Images were captured on a confocal microscope (Leica DMI 4000B).
Mice and hormone treatments
All mouse experimental procedures followed a protocol approved by the Washington University in St. Louis Institutional Animal Care and Use Committee (Protocol Number 20191079). CD1 wild-type mice (Charles River, Saint Louis, Missouri) were maintained on a 12-h light:12-h dark cycle. Sexually mature (8-week-old) CD1 females were mated to fertile wild-type males, and copulation was confirmed by the presence of vaginal plug on the following morning, designated as 1 day post-coital (dpc). Mice were euthanized, and uteri were collected on 1, 2, 3, 4, 5, and 6 dpc. To determine the uterine estrogen or progesterone responses, six-week-old CD1 mice were bilaterally ovariectomized, rested for two weeks to allow the endogenous ovarian-derived steroid hormones to dissipate, and then subcutaneously injected with 100 μl sesame oil (vehicle control), 1 mg progesterone, or 100 ng estradiol (Sigma-Aldrich) in 100 μl sesame oil. Six hours later, mice were euthanized, uterine tissues were collected and fixed in 4% paraformaldehyde, and RNA was isolated and processed for qRT-PCR (Kommagani et al. 2016).
Statistical analyses
A two-tailed paired Student t-test was used to analyze experiments with two experimental groups, and analysis of variance by non-parametric alternatives was used for multiple comparisons to analyze experiments containing more than two groups. P<0.05 was considered significant. All data are presented as mean ± SEM. GraphPad Prism 8 software was used for all statistical analyses.
Author contribution statement
RK conceived the project, supervised the work, analyzed the data, and wrote the manuscript. SBC, VKM, and PP, conducted the studies and wrote the manuscript. All authors reviewed and approved the final version of the manuscript.
Funding
This work was funded, in part, by National Institutes of Health/National Institute of Child Health and Human Development grants R00HD080742 and RO1HD065435 to RK and Washington University School of Medicine start-up funds to RK.
Declaration of Interest
The authors have no conflicts of interest to declare.
Acknowledgments
We thank Dr. Deborah J. Frank (Department of Obstetrics and Gynecology, Washington University) for assistance with manuscript editing.
Footnotes
The authors have declared that no conflict of interest exists relating to this work.
Non-standard Abbreviations
- SARS-CoV-2
- severe acute respiratory syndrome coronavirus
- ACE2
- Angiotensin converting enzyme 2
- WT
- Wild Type
- HESC
- Human Endometrial Stromal Cells
- dpc
- Days Post Coitum
- E2
- Estrogen
- P4
- Progesterone